• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3

CATEGORIES

  • 6
  • 5
  • 3
  • 2
  • 2

PRICE

9
11
11
14

PUBLISHED

2
2
5
14

PRODUCT TYPE

10
4

Search "Salix Pharmaceuticals, Ltd.-Deals & Alliances Report" returned 14 results.

PRODUCT TITLE
Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report - Product Thumbnail Image

Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report

Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service...

November 2014
FROM
Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review

Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review Summary Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company focusing on licensing, developing...

September 2011
FROM

Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

August 2014
FROM

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM
Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million Annual estimates and forecasts are provided for the period 2006 through 2015 The report profiles 69...

April 2010
FROM
Salix Pharmaceuticals, Ltd.-Detailed Product Pipeline Salix Pharmaceuticals, Ltd.-Detailed Product Pipeline - Product Thumbnail Image

Salix Pharmaceuticals, Ltd.-Detailed Product Pipeline

Salix Pharmaceuticals, Ltd.-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and...

March 2011
FROM
Prescription Drugs - Global Strategic Business Report Prescription Drugs - Global Strategic Business Report - Product Thumbnail Image

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

July 2009
FROM
Cancer Diagnostics Partnering Terms and Agreements (3rd Edition) Cancer Diagnostics Partnering Terms and Agreements (3rd Edition) - Product Thumbnail Image

Cancer Diagnostics Partnering Terms and Agreements (3rd Edition)

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. ...

December 2014
FROM

Eisai Inc. - Strategic SWOT Analysis Review

Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,...

July 2014
FROM
Salix Pharmaceuticals Ltd.-Detailed Product Pipeline Salix Pharmaceuticals Ltd.-Detailed Product Pipeline - Product Thumbnail Image

Salix Pharmaceuticals Ltd.-Detailed Product Pipeline

Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

March 2008
FROM

Santarus, Inc. (SNTS) - Financial and Strategic SWOT Analysis Review

Summary Santarus, Inc. (Santarus) is a specialty biopharmaceutical company. It acquires, develops and commercializing pharmaceutical products. The company’s marketed products consists of Uceris (budesonide)...

March 2013
FROM
Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review

Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review Summary Pharmos Corporation (Pharmos) is a biopharmaceutical company, principally engaged in the discovery and development...

September 2011
FROM
Salix Pharmaceuticals Ltd.-Therapeutic Competitors Salix Pharmaceuticals Ltd.-Therapeutic Competitors - Product Thumbnail Image

Salix Pharmaceuticals Ltd.-Therapeutic Competitors

Salix Pharmaceuticals Ltd.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...

March 2008
FROM
Eisai Co., Ltd. - Product Pipeline Review - H2 2011 Eisai Co., Ltd. - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Eisai Co., Ltd. - Product Pipeline Review - H2 2011

Eisai Co., Ltd. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Eisai Co., Ltd. - Product Pipeline Review - H2 2011” provides data on the Eisai Co., Ltd.’s...

November 2011
FROM
Loading Indicator

Our Clients

Our clients' logos